Cardinal Health is a global healthcare services and products company that plays a vital role in the medical supply chain. It specializes in the distribution of pharmaceuticals and medical supplies to healthcare institutions, pharmacies, and patients. In addition to its distribution services, the company also manufactures and provides a wide range of medical and surgical products, including surgical gloves, apparel, and other healthcare-related items. Cardinal Health is committed to enhancing patient care by ensuring the availability of essential products and services, while also striving to improve the efficiency and effectiveness of healthcare delivery across various settings. Read More
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Marjorie Taylor Greene disclosed buying more than 50 stocks in early May. A look at the list and why the congresswoman's past trades have drawn red flags.
Healthcare distributor and services company Cardinal Health (NYSE:CAH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $54.88 billion. Its non-GAAP profit of $2.35 per share was 9.4% above analysts’ consensus estimates.
Healthcare distributor and services company Cardinal Health (NYSE:CAH)
will be reporting earnings tomorrow before market open. Here’s what you need to know.
Cardinal Health is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at healthcare distribution & related services stocks, starting with Patterson Companies (NASDAQ:PDCO).
MELBOURNE, Australia and INDIANAPOLIS, April 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as one of its commercial radiopharmaceutical distributors to supply finished unit doses of Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), Telix’s next-generation PSMA-PET imaging1 agent for prostate cancer in the United States (U.S.).
Since April 2020, the S&P 500 has delivered a total return of 87.2%. But one standout stock has nearly doubled the market - over the past five years, Cardinal Health has surged 159% to $127.74 per share. Its momentum hasn’t stopped as it’s also gained 13.4% in the last six months thanks to its solid quarterly results, beating the S&P by 23.9%.
The S&P 500 is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Cardinal Health (NYSE:CAH) and the best and worst performers in the healthcare providers & services industry.
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital,
and those that can maintain this trifecta year in and year out often become the legends of the investing world.
Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm's technology exposure.
Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP profit of $1.93 per share was 9.4% above analysts’ consensus estimates.
